NABL asks accredited CABs to incorporate report & certificate authentication mechanisms: Shardul Nautiyal, Mumbai Saturday, ...

Brentwood, Tennessee Saturday, March 22, 2025, 13:00 Hrs [IST] ...

Dizal announces new findings on golidocitinib; to present clinical results at ELCC 2025 in Paris on March 26-29: Shanghai Saturday, March 22, 2025, 17:00 Hrs [IST] Dizal, a biopha ...

EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...

Elevation Oncology to discontinue development of EO-3021, a Claudin 18.2 ADC to treat advanced unresectable or metastatic gastric and GEJ: Boston Saturday, March 22, 2025, 15:00 H ...

NIH-funded study illuminates the structural features of memory formation at cellular and subcellular levels: Bethesda, Maryland Saturday, March 22, 2025, 14:00 Hrs [IST] In a stud ...

Coronado Research, a consultancy-led, professional services organisation, has appointed Gary Lyons as EVP Medical Affairs. Gary is a seasoned senior Medical Affairs leader with extensive strategic and ...

Actinium Pharma inks research pact with Memorial Sloan Kettering to support further clinical expansion of Actimab-A's backbone therapy strategy: New York Saturday, March 22, 2025, ...

Leiden, the Netherlands Saturday, March 22, 2025, 12:00 Hrs [IST] ...

Indian hospitals work to reduce sepsis incidents as US FDA norms stresses on close patient observation: Nandita Vijayasimha, Bengaluru Saturday, March 22, 2025, 08:00 Hrs [IST] In ...

US FDA approves Novartis’ oral Fabhalta for treatment of adults with C3 glomerulopathy: Basel Saturday, March 22, 2025, 09:00 Hrs [IST] Novartis announced that oral Fabhalta (ip ...

Peethaambaran Kunnathoor, Chennai Saturday, March 22, 2025, 08:00 Hrs [IST] ...